Eli Lilly wasn’t about to lose out on this one: Federal Trade Commission OKs licensing agreement on new

Prozac. “The Federal Trade

Commission has approved Eli Lilly and Co.’s deal to license a new and improved version of the

popular antidepressant Prozac, the company said Thursday.” Lilly’s main patent on Prozac expires in 2003, and it has been hellbent on finding a way to fend off the appeal of cheaper generic versions that may then start to erode its market share drastically.